Latest NewsGlenmark Pharma signs agreement with SeqirusadminJuly 6, 2018 by adminJuly 6, 201801135 Glenmark Pharma’s subsidiary Glenmark Specialty, has entered into an exclusive licensing agreement with Australia’s Seqirus to commercialize its nasal spray, Ryaltris in Australia and New...